bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Bilirubinemia

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Bilirubinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dragovich, T; Hoos, A; Kurtin, S; Mendelson, D; Richardson, K; Von Hoff, D	1

Trials

1 trial(s) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Bilirubinemia

Article	Year
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:6 Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Hematologic Diseases; Humans; Hyperbilirubinemia; Liposomes; Male; Middle Aged; Nausea; Neoplasm Staging; Organoplatinum Compounds; Peripheral Nervous System Diseases; Treatment Outcome; Vomiting	2006

Article

Year

A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.

Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:6

Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Hematologic Diseases; Humans; Hyperbilirubinemia; Liposomes; Male; Middle Aged; Nausea; Neoplasm Staging; Organoplatinum Compounds; Peripheral Nervous System Diseases; Treatment Outcome; Vomiting

2006